Equities

BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust

Actions
FinancialsClosed End Investments
  • Price (USD)14.51
  • Today's Change-0.14 / -0.96%
  • Shares traded131.99k
  • 1 Year change-11.90%
  • Beta0.9153
Data delayed at least 15 minutes, as of Apr 18 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, diversified financial services, health care technology, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.

  • Revenue in USD (TTM)13.15m
  • Net income in USD69.86m
  • Incorporated2019
  • Employees--
  • Location
    BlackRock Health Sciences Term Trust100 Bellevue ParkwayWILMINGTON 19809United StatesUSA
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cohen & Steers Qlty Inc Realty Fund Inc-100.00bn-100.00bn1.46bn0.00------------------------------------------------------------
Blackrock Enhanced Equity Dividend Trust-100.00bn-100.00bn1.47bn0.00------------------------------------------------------------
Apollo Commercial Real Estate Financ Inc810.70m41.50m1.48bn0.0039.400.667527.391.830.26470.26475.6015.630.086--11.77--0.61622.040.63812.6042.5156.287.1728.96--2.500.759155.3541.2014.95-83.32-26.17---5.32
Oaktree Specialty Lending Corp398.09m114.69m1.53bn0.0012.951.01--3.851.501.505.2219.140.132--12.01--3.805.093.915.2877.4371.6128.8148.09--1.610.517790.1544.4822.28301.5020.20--12.79
Royce Value Trust Inc22.28m329.64m1.55bn50.004.780.8471--69.722.912.910.196316.420.0126--3.03--18.5710.2018.6310.23-0.370525.411,479.54782.20----0.018466.54-6.08-2.85171.57-----1.04
Nuveen California Quality Muncpl IncmFnd79.45m-34.71m1.56bn----0.8757--19.64-0.2398-0.23980.548912.310.0256--1.56---1.120.4242-1.130.427317.1561.49-43.6812.85--0.27370.4116615.74-85.49-35.13-963.60-----5.93
Tri-Continental Corp67.10m253.08m1.56bn--6.070.8954--23.274.824.821.2833.370.0398--4.85--15.0210.6715.0510.6989.6288.89377.16287.45----0.0065.97-1.631.83186.61----3.15
BlackRock Health Sciences Term Trust13.15m69.86m1.58bn--23.160.8181--120.390.63270.63270.123417.910.0065--10.77--3.46--3.47---87.50--531.41------0.0002--42.99--110.23------
Kayne Anderson Energy Infrstctr Fund Inc69.56m112.59m1.61bn--18.330.9077--23.200.52030.52030.411310.510.0314--6.01--5.08-1.295.13-1.3238.40-10.13161.86-64.83----0.2191--22.0322.32-65.1823.79---14.34
BlackRock Innovation and Growth Trm Trst4.44m211.57m1.63bn--7.710.7951--367.090.93170.93170.01989.030.0022--1.96--10.26--10.33---486.14--4,767.08------0.01--26.47--112.77------
BlackRock ESG Capital Allocatin Trm Trst59.33m294.92m1.66bn--5.730.8966--27.922.822.820.582318.050.0296--13.31--14.73--16.17--62.15--497.10------0.0041--38.89--194.26------
BlackRock Capital Allocation Term Trust84.08m204.72m1.66bn--8.080.891--19.771.901.900.782517.250.0391--7.74--9.52--10.64--72.68--243.48------0.00---3.48--163.48------
Compass Diversified Holdings2.06bn-108.21m1.67bn4.39k--1.6320.400.8104-1.502.6728.5717.630.53711.586.24468,565.30-1.01-0.5496-1.18-0.647643.3939.15-1.88-0.94242.76-0.92350.5239--2.488.69-220.52--2.08-7.03
Eaton Vance Tax-Advantgd Divdnd Incm Fnd-100.00bn-100.00bn1.67bn--------------------------------------------------------------
Cornerstone Strategic Value Fund Inc.-100.00bn-100.00bn1.69bn--------------------------------------------------------------
Goldman Sachs BDC Inc454.91m195.87m1.70bn--8.401.03--3.731.801.804.2014.620.1279------5.514.565.644.6656.5363.3143.0644.31--4.870.5328114.8027.2725.40256.1229.55--0.00
Data as of Apr 18 2024. Currency figures normalised to BlackRock Health Sciences Term Trust's reporting currency: US Dollar USD

Institutional shareholders

30.81%Per cent of shares held by top holders
HolderShares% Held
Saba Capital Management LPas of 01 Apr 202420.54m18.23%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 20233.25m2.89%
RiverNorth Capital Management LLCas of 31 Dec 20231.97m1.75%
1607 Capital Partners LLCas of 31 Dec 20231.56m1.38%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Dec 20231.54m1.37%
Invesco Capital Management LLCas of 31 Dec 20231.35m1.20%
Almitas Capital LLCas of 31 Dec 20231.29m1.15%
UBS Financial Services, Inc.as of 31 Dec 20231.28m1.13%
Karpus Management, Inc.as of 31 Dec 20231.22m1.08%
Wells Fargo Clearing Services LLCas of 31 Dec 2023707.65k0.63%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.